Evidence map›Paper›PMID 25451919›Full record

ArticleThe Journal of biological chemistry2015

Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes.

YongQiang Wang, Sung-Mi Kim, Michael J Trnka, Yi Liu, A L Burlingame, Maria Almira Correia

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Posttranslational regulation of CYP2J2 by nitric oxide.Free radical biology & medicine · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

YongQiang WangFrom the Departments of Cellular and Molecular Pharmacology.
Sung-Mi KimFrom the Departments of Cellular and Molecular Pharmacology.
Michael J TrnkaPharmaceutical Chemistry, and.
Yi LiuFrom the Departments of Cellular and Molecular Pharmacology.
A L BurlingamePharmaceutical Chemistry, and.
Maria Almira CorreiaFrom the Departments of Cellular and Molecular Pharmacology, Pharmaceutical Chemistry, and Bioengineering and Therapeutic Sciences, The Liver Center, University of California at San Francisco, San Francisco, California 94158-2517 almira.correia@ucsf.edu.
University of California, San Francisco · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
HEPATIC DEGRADATION OF P450P ISOZYMESR01GM044037 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 1990 to 2023
$8.0M
REGULATION OF HEME METABOLISM IN THE LIVERR01DK026506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 1986 to 2016
$7.1M
Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Influence of Heme on Hepatic Cytochrome P450 Synthesis and DegradationR56DK026506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 2007 to 2007
$500k
NIDDK NIH HHS DK26506NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK026506NIDDK NIH HHS R56 DK026506NIGMS NIH HHS 8P41GM103481NIGMS NIH HHS GM44037NIGMS NIH HHS P41 GM103481NIGMS NIH HHS R01 GM044037
6 · The paper itself

Abstract

CYP3A4 is an abundant and catalytically dominant human liver endoplasmic reticulum-anchored cytochrome P450 enzyme engaged in the biotransformation of endo- and xenobiotics, including >50% of clinically relevant drugs. Alterations of CYP3A4 protein turnover can influence clinically relevant drug metabolism and bioavailability and drug-drug interactions. This CYP3A4 turnover involves endoplasmic reticulum-associated degradation via the ubiquitin (Ub)-dependent 26 S proteasomal system that relies on two highly complementary E2 Ub-conjugating-E3 Ub-ligase (UBC7-gp78 and UbcH5a-C terminus of Hsc70-interacting protein (CHIP)-Hsc70-Hsp40) complexes, as well as protein kinases (PK) A and C. We have documented that CYP3A4 Ser/Thr phosphorylation (Ser(P)/Thr(P)) by PKA and/or PKC accelerates/enhances its Lys ubiquitination by either of these E2-E3 systems. Intriguingly, CYP3A4 Ser(P)/Thr(P) and ubiquitinated Lys residues reside within the cytosol-accessible surface loop and/or conformationally assembled acidic Asp/Glu clusters, leading us to propose that such post-translational Ser/Thr protein phosphorylation primes CYP3A4 for ubiquitination. Herein, this possibility was examined through various complementary approaches, including site-directed mutagenesis, chemical cross-linking, peptide mapping, and LC-MS/MS analyses. Our findings reveal that such CYP3A4 Asp/Glu/Ser(P)/Thr(P) surface clusters are indeed important for its intermolecular electrostatic interactions with each of these E2-E3 subcomponents. By imparting additional negative charge to these Asp/Glu clusters, such Ser/Thr phosphorylation would generate P450 phosphodegrons for molecular recognition by the E2-E3 complexes, thereby controlling the timing of CYP3A4 ubiquitination and endoplasmic reticulum-associated degradation. Although the importance of phosphodegrons in the CHIP targeting of its substrates is known, to our knowledge this is the first example of phosphodegron involvement in gp78-substrate recruitment, an important step in CYP3A4 proteasomal degradation.

Indexed as

UbiquitinationAmino Acid SequenceAnimalsCytochrome P-450 CYP3AHEK293 CellsHumansMiceMolecular Sequence DataPhosphorylationProtein BindingProtein Structure, TertiaryReceptors, Autocrine Motility FactorUbiquitin-Protein LigasesAMFR protein, humanCYP3A4 protein, humanCytochrome P-450 CYP3AReceptors, Autocrine Motility FactorUbiquitin-Protein LigasesCHIPCYP3A4Cytochrome P450E3 Ubiquitin LigaseEndoplasmic Reticulum-associated Protein Degradation (ERAD)gp78/AMFRMass Spectrometry (MS)Protein PhosphorylationUbiquitin-conjugating Enzyme (E2 enzyme)Ubiquitylation (ubiquitination)

Identifiers

PMID25451919
PMCPMC4319004
OpenAlexW2069088966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.